loading
Rockwell Medical Inc stock is traded at $1.14, with a volume of 319.25K. It is down -1.30% in the last 24 hours and up +0.88% over the past month. Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
See More
Previous Close:
$1.155
Open:
$1.16
24h Volume:
319.25K
Relative Volume:
1.19
Market Cap:
$39.25M
Revenue:
$98.92M
Net Income/Loss:
$-1.24M
P/E Ratio:
-19.00
EPS:
-0.06
Net Cash Flow:
$2.64M
1W Performance:
+11.76%
1M Performance:
+0.88%
6M Performance:
-35.59%
1Y Performance:
-61.49%
1-Day Range:
Value
$1.13
$1.1999
1-Week Range:
Value
$0.99
$1.1999
52-Week Range:
Value
$0.7801
$5.15

Rockwell Medical Inc Stock (RMTI) Company Profile

Name
Name
Rockwell Medical Inc
Name
Phone
(800) 449-3353
Name
Address
30142 WIXOM ROAD, WIXOM, NJ
Name
Employee
244
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
RMTI's Discussions on Twitter

Compare RMTI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
RMTI
Rockwell Medical Inc
1.14 36.15M 98.92M -1.24M 2.64M -0.06
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
156.62 67.51B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.52 47.88B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.82 43.42B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.46 20.72B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
312.23 14.21B 2.99B 1.21B 1.13B 25.06

Rockwell Medical Inc Stock (RMTI) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-14-24 Initiated Rodman & Renshaw Buy
Jun-24-19 Initiated Piper Jaffray Overweight
May-13-19 Initiated H.C. Wainwright Buy
Nov-08-16 Downgrade BofA/Merrill Neutral → Underperform
Mar-01-16 Downgrade Stifel Buy → Hold
Aug-13-15 Initiated Morgan Stanley Underweight
Jan-27-15 Reiterated Oppenheimer Outperform
Jan-07-15 Initiated Oppenheimer Outperform
Aug-14-14 Initiated FBR Capital Underperform
Dec-19-13 Initiated Chardan Capital Markets Buy
Nov-06-13 Reiterated Summer Street Research Buy
Sep-05-13 Reiterated Summer Street Research Buy
Aug-02-13 Reiterated Summer Street Research Buy
Apr-11-12 Initiated Summer Street Research Buy
Mar-12-12 Initiated Stifel Nicolaus Buy
Jan-03-12 Initiated Canaccord Genuity Buy
Dec-10-09 Initiated JMP Securities Mkt Outperform
Oct-12-09 Initiated Wedbush Morgan Outperform
View All

Rockwell Medical Inc Stock (RMTI) Latest News

pulisher
Aug 20, 2025

Key metrics from Rockwell Medical Inc.’s quarterly dataJuly 2025 Drop Watch & Weekly Setup with High ROI Potential - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Real time scanner hits for Rockwell Medical Inc. explained2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Order flow analysis tools used on Rockwell Medical Inc.2025 Analyst Calls & Safe Entry Point Identification - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Applying big data sentiment scoring on Rockwell Medical Inc.Portfolio Update Summary & Smart Investment Allocation Insights - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Combining machine learning predictions for Rockwell Medical Inc.Jobs Report & Verified Chart Pattern Signals - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Rockwell Medical Inc.’s Beta Climbs After Market VolatilityWeekly Profit Recap & Entry Point Confirmation Signals - classian.co.kr

Aug 19, 2025
pulisher
Aug 19, 2025

Chart based exit strategy for Rockwell Medical Inc.Portfolio Gains Report & Comprehensive Market Scan Reports - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Is now a turning point for Rockwell Medical Inc.Portfolio Update Report & Free Expert Verified Stock Movement Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Using AI based signals to follow Rockwell Medical Inc.July 2025 Opening Moves & Expert Verified Stock Movement Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Rockwell Medical, Inc. (NASDAQ:RMTI) Shares Could Be 34% Below Their Intrinsic Value Estimate - simplywall.st

Aug 19, 2025
pulisher
Aug 19, 2025

Is Rockwell Medical Inc. stock poised for growthWeekly Risk Report & Capital Efficiency Focused Strategies - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Using portfolio simulators with Rockwell Medical Inc. includedBull Run & Low Drawdown Trading Techniques - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Rockwell Medical’s Growth Potential and Stability: A Buy Rating by Ram Selvaraju - TipRanks

Aug 18, 2025
pulisher
Aug 18, 2025

Trend analysis for Rockwell Medical Inc. this weekCEO Change & Verified Technical Signals - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Rockwell Medical Posts Q2 Loss Amid Weak Operating Performance—Market Reaction Signals Heightened Sensitivity - AInvest

Aug 18, 2025
pulisher
Aug 17, 2025

Using Bollinger Bands to evaluate Rockwell Medical Inc.Chart Signals & Free Fast Gain Swing Trade Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

What institutional flow reveals about Rockwell Medical Inc.Market Sentiment Summary & Long-Term Safe Investment Ideas - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Live market analysis of Rockwell Medical Inc.Weekly Risk Report & Verified Entry Point Signals - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Rockwell Medical Posts Second Earnings Miss in Q2 2025 Amid Rising Costs — Market Reacts Poorly - AInvest

Aug 17, 2025
pulisher
Aug 17, 2025

Can trapped investors hope for a rebound in Rockwell Medical Inc.Portfolio Performance Report & Reliable Entry Point Trade Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Rockwell Medical reiterates $65M-$70M sales target for 2025 as new contracts expand long-term revenue base - MSN

Aug 17, 2025
pulisher
Aug 17, 2025

Is it time to cut losses on Rockwell Medical Inc.2025 Market Trends & Community Supported Trade Ideas - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Rockwell Medical's Strategic Positioning and Growth Potential Justifies Buy Rating, Says Analyst Anthony Vendetti. - AInvest

Aug 16, 2025
pulisher
Aug 16, 2025

How institutional ownership impacts Rockwell Medical Inc. stockJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Applying Elliott Wave Theory to Rockwell Medical Inc.July 2025 Outlook & Daily Chart Pattern Signals - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

What’s the recovery path for long term holders of Rockwell Medical Inc.Share Buyback & Free Daily Entry Point Trade Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Will Rockwell Medical Inc. rebound enough to break evenWeekly Gains Summary & Fast Exit and Entry Trade Guides - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Rockwell Medical: Strategic Positioning and Growth Potential Justify Buy Rating - TipRanks

Aug 15, 2025
pulisher
Aug 15, 2025

Rockwell Medical, Inc. (NASDAQ:RMTI) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 15, 2025
pulisher
Aug 15, 2025

Rockwell Medical Q2 2025 Earnings: Revenue Down 38% - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

Rockwell Medical 2025 Q2 Earnings Significant Loss as Net Income Plummets 535% - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

Rockwell Medical: Q2 Earnings Snapshot - Norwalk Hour

Aug 15, 2025
pulisher
Aug 15, 2025

Rockwell Medical Reports Q2 2025 Financial Results - TipRanks

Aug 15, 2025

Rockwell Medical Inc Stock (RMTI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Rockwell Medical Inc Stock (RMTI) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Neri Jesse
SVP and CFO
Jul 01 '25
Sale
0.82
886
727
126,614
Strobeck Mark
President and CEO
Jul 01 '25
Sale
0.82
6,926
5,679
337,752
$29.75
price up icon 2.37%
$17.91
price up icon 2.40%
drug_manufacturers_specialty_generic RDY
$14.51
price up icon 0.62%
$10.65
price down icon 0.37%
$135.43
price up icon 0.11%
$312.23
price up icon 0.51%
Cap:     |  Volume (24h):